Next Science Limited
NXSCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 2.9% | 89.4% | 30.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 80.8% | 73.2% | 101.6% | 66.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -39.6% | -65% | -100.5% | -103% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -46.4% | -110.5% | -156.2% | -100.9% |
| EPS Diluted | -0.036 | -0.07 | -0.087 | -0.048 |
| % Growth | 47.8% | 20% | -82.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |